Elevated baseline resting heart rate (RHR) is associated with an increased risk for incident atrial fibrillation (AF) ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...

An elevated heart rate could provide an important clue to which Black adults often have a dangerous heart rhythm disorder, a ...

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

Boston Scientific ( (BSX) ) just unveiled an announcement. Boston Scientific Corporation has announced the resumption of its AVANT GUARD ...

He determined that I had a slight atrial fibrillation and mildly obstructed carotids. Subsequent annual testing has shown ...

Atrial fibrillation (AF) is one of the most common types of arrhythmia, affecting millions worldwide. As healthcare systems ...

Dr. Mehran Attari, a cardiac electrophysiologist with Mercy Health, discusses a new treatment option for atrial fibrillation (AFib): pulse field ablation (PFA). Atrial fibrillation is the most common ...

The trial was small and halted early, but investigators say the inflammatory hypothesis in TAVI is worth pursuing further.

Since rolling out its pulsed field ablation system for treating atrial fibrillation earlier this year, Boston Scientific has ...